These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34681616)

  • 1. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
    Hosaka T; Tsuji H; Kwak S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inefficient A-to-I RNA editing and ALS].
    Kwak S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):978. PubMed ID: 21921533
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
    Yamashita T; Kwak S
    Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets.
    Hosaka T; Tsuji H; Kwak S
    Cells; 2023 May; 12(10):. PubMed ID: 37408276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
    Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
    EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yamashita T; Akamatsu M; Kwak S
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
    Sasaki S; Yamashita T; Kwak S
    Neurosci Lett; 2015 Jun; 598():79-84. PubMed ID: 25980994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice.
    Hideyama T; Teramoto S; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2024 Aug; 463():123142. PubMed ID: 39053342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2.
    Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE
    J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
    Habib MZ; Elnahas EM; Aboul-Ela YM; Ebeid MA; Tarek M; Sadek DR; Negm EA; Abdelhakam DA; Aboul-Fotouh S
    Eur J Pharmacol; 2023 Sep; 955():175916. PubMed ID: 37460052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.
    Akamatsu M; Yamashita T; Teramoto S; Huang Z; Lynch J; Toda T; Niu L; Kwak S
    Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35022247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.
    Mahajan SS; Thai KH; Chen K; Ziff E
    Neuroscience; 2011 Aug; 189():305-15. PubMed ID: 21620933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.